The above data show that the 1-year, 2-year, 3-year, 5-year, and 10-year DFS rates of NBNC-AFP(-)-HCC patients were 84.6%, 72.9%, 68.8%, 51%, and 40.8%, respectively, and the patients’ median DFS duration was 90 months. This evidence concerns the gene AFP and hepatocellular carcinoma.